Insiders · Profile

GOLDBERG Y. PAUL

VP of Clinical Development at Xenon Pharmaceuticals. Filing since 22 Sep 2015. CIK 0001619960

Company
Date
Role
Action
Shares
Amount
Of holding
24 Sep 2015
VP of Clinical Development
Sold, plan not stated
12,000
$103.20K
66.7%
23 Sep 2015
VP of Clinical Development
Sold, plan not stated
4,000
$36.08K
18.2%
22 Sep 2015
VP of Clinical Development
Sold, plan not stated
6,149
$57.38K
21.8%
3 decisions on file.